Frontlight ResearchEarly access
Active, not recruitingPhase 4
Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.
Key facts
- Who runs it
- Kasr El Aini Hospital
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 59 people enrolled
- Started
- 15 Sept 2024
- Ended
- 1 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- NB-UVB alone
- NB-UVB combined with carboxy
- Record updated
- 1 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Subjects with stable non-segmental vitiligo (≥2 symmetrical patches of diameter less than 2 cm on acral or ≥ 2 symmetrical patches on non-acral sites). Subjects were stable for twelve or more months
Who cannot take part
- Subjects with unstable vitiligo; Subjects with segmental vitiligo; Pregnant females; Severe anemia (Hb <7 gm/dl); Cardiac/hepatic/renal/respiratory failure; Superficial thrombophlebitis; Subjects with history of skin malignancy or precancerous conditions like Xeroderma pigmentosum; Subjects with other autoimmune disorders; Systemic drugs for vitiligo in the last 3 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Patients with stable vitiligo with 2 or more symmetric patches, 2 on acral sites and/or 2 on non acral sites will be recruited and assessed for eligibility for inclusion to receive NB-UVB on the whole body, and carboxytherapy on one randomized side.
The 2 groups in the trial
- NB-UVBPlacebo, for comparison
Treatment: NB-UVB alone
- NB-UVB combined with carboxyExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation Of Carboxytherapy As An Adjuvant To Narrowband-Ultraviolet B Phototherapy For The Treatment Of Stable Non-Segmental Vitiligo: A Clinical And Biochemical Study .
- Record updated
- 1 May 2026